Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
Hammersmith Hospital · Imperial College London · +7 more institutions
Abstract
The colonic microbiota ferment dietary fibres, producing short chain fatty acids. Recent evidence suggests that the short chain fatty acid propionate may play an important role in appetite regulation. We hypothesised that colonic delivery of propionate would increase peptide YY (PYY) and glucagon like peptide-1 (GLP-1) secretion in humans, and reduce energy intake and weight gain in overweight adults.
To investigate whether propionate promotes PYY and GLP-1 secretion, a primary cultured human colonic cell model was developed. To deliver propionate specifically to the colon, we developed a novel inulin-propionate ester. An acute randomised, controlled cross-over study was used to assess the effects of this inulin-propionate ester on energy intake and plasma PYY and GLP-1 concentrations. The long-term effects of inulin-propionate ester on weight gain were subsequently assessed in a randomised, controlled 24-week study involving 60 overweight adults.
Citation impact
- FWCI
- 20.06
- Percentile
- 100%
- References
- 53
Authors
22- ESEdward S. Chambers
Hammersmith Hospital, Imperial College London
- AVAlexander Viardot
Garvan Institute of Medical Research, Hammersmith Hospital, Imperial College London
- APArianna Psichas
Hammersmith Hospital, Imperial College London
- DJDouglas J. Morrison
Scottish Universities Environmental Research Centre, University of Glasgow
- KGKevin G. Murphy
Hammersmith Hospital, Imperial College London
Topics & keywords
- Overweight
- Appetite
- Medicine
- Body weight
- Propionate
- Weight management
- Obesity
- Internal medicine
- Affordable and clean energy
Funding
- WTWellcome Trust
- NINational Institute for Health and Care ResearchAward: FP7-HEALTH-2009-241592
- ICImperial College London
- DFDirectorate for Biological Sciences
- MRMedical Research CouncilAward: FP7-HEALTH-2009-241592
- BABiotechnology and Biological Sciences Research CouncilAwards: BB/L004259/1, BB/H004971/1, BB/H004815/1, BB/H005072/1, BB/H004971/1, FP7-HEALTH-2009-241592
- NHNational Health and Medical Research Council
- NINIHR Imperial Biomedical Research Centre
- FHFP7 Health